Therapeutics

The Australian College of Optometry (ACO) has announced that its Certificate in Ocular Therapeutics (COT) will now run every two...

A gene therapy developed by scientists in the UK has been granted orphan drug designation by the US FDA and...

Adelaide-based Nova Eye Medical has announced the publication of six-year data of its iTrack canaloplasty microcatheter. Published in the Journal...

AFT Pharmaceuticals is highly selective about the products it brings to the Australasian market – and its eyecare portfolio exemplifies...

Glaukos has commenced Phase 2 trials of two investigational cream-based drug candidates that are applied to the eyelids to treat...

Pharmaceutical firm Seqirus has announced that its new therapy Ikervis is now available via the Pharmaceutical Benefits Scheme (PBS), making...

Pharmaceutical company Seqirus has announced that preservative-free dry eye therapy Cationorm is now accessible via the Pharmaceutical Benefits Scheme (PBS)...

Allergan has secured regulatory approval for an alternative product to address a Prednefrin Forte shortage in Australia. The company confirmed...

The Therapeutic Goods Administration (TGA) has confirmed a shortage of Prednefrin Forte 10mL eye drops in Australia, which isn't expected...

Novartis has announced positive findings from its the Phase 3 trial assessing the efficacy and safety of Beovu (brolucizumab) to...